ciprofloxacin has been researched along with Anal Fistula in 17 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Excerpt | Relevance | Reference |
---|---|---|
"To evaluate, in a prospective, open-label study, the influence of antibiotics and azathioprine on the clinical outcome of perianal fistulas in patients with Crohn's disease." | 9.10 | Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. ( Dejaco, C; Harrer, M; Miehsler, W; Reinisch, W; Vogelsang, H; Waldhoer, T, 2003) |
"Ciprofloxacin was well tolerated." | 6.74 | Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. ( Bernstein, CN; Bitton, A; Cockeram, A; Feagan, BG; Mahadevan, U; Sandborn, WJ; Thia, KT; Wong, C, 2009) |
"Ciprofloxacin is effective in perianal Crohn's disease but after treatment discontinuation symptoms reoccur." | 6.71 | Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study. ( Drapers, JA; Felt-Bersma, RJ; Hansen, BE; Kuipers, EJ; van der Woude, CJ; van Tilburg, AJ; West, RL, 2004) |
"In this study we aimed to determine the microorganisms found in perianal fistulas in Crohn's disease and whether treatment with ciprofloxacin affects these microorganisms." | 5.11 | Perianal fistulas in Crohn's disease are predominantly colonized by skin flora: implications for antibiotic treatment? ( Boelens, HA; Endtz, HP; Hansen, BE; Kuipers, EJ; Kusters, JG; Ouwedijk, M; Van der Woude, CJ; West, RL, 2005) |
"To evaluate, in a prospective, open-label study, the influence of antibiotics and azathioprine on the clinical outcome of perianal fistulas in patients with Crohn's disease." | 5.10 | Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. ( Dejaco, C; Harrer, M; Miehsler, W; Reinisch, W; Vogelsang, H; Waldhoer, T, 2003) |
"Fifty-two patients (median age 36 yr) with draining perianal fistulas were treated with ciprofloxacin (N = 49) or metronidazole (N = 3) for a median duration of 7 wk." | 3.74 | NOD2/CARD15 gene variants are linked to failure of antibiotic treatment in perianal fistulating Crohn's disease. ( Angelberger, S; Dejaco, C; Lichtenberger, C; Miehsler, W; Reinisch, W; Schaeffeler, E; Schwab, M; Teml, A; Vogelsang, H; Waldhoer, T; Wehkamp, J, 2008) |
"Ciprofloxacin was well tolerated." | 2.74 | Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. ( Bernstein, CN; Bitton, A; Cockeram, A; Feagan, BG; Mahadevan, U; Sandborn, WJ; Thia, KT; Wong, C, 2009) |
"Ciprofloxacin is effective in perianal Crohn's disease but after treatment discontinuation symptoms reoccur." | 2.71 | Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study. ( Drapers, JA; Felt-Bersma, RJ; Hansen, BE; Kuipers, EJ; van der Woude, CJ; van Tilburg, AJ; West, RL, 2004) |
" Moreover, long-term use of glucocorticosteroids is associated with serious and sometimes irreversible side effects." | 2.42 | An historical overview of the treatment of Crohn's disease: why do we need biological therapies? ( Rutgeerts, PJ, 2004) |
"Stool samples and rectal and perianal fistula swabs were collected." | 1.72 | A Microbial Signature for Paediatric Perianal Crohn's Disease. ( Albenberg, L; Baldassano, RN; Bittinger, K; Breton, J; Devas, N; Hwang, R; Kachelries, K; Mattei, P; Rowley, S; Tanes, C; Tu, V; Wu, GD, 2022) |
"It is extremely rare that the urinary bladder stones cause vesicorectal fistulas." | 1.40 | Is vesicolithotomy with bladder wash the answer for rectovesical fistula secondary to neglected vesical stone? Complicated presentation but simple management. ( Elnaim, AK; Mohamed, MM, 2014) |
"Genital fistulas are a significant problem in female Crohn's disease patients." | 1.38 | Genital fistulas in female Crohn's disease patients.: clinical characteristics and response to therapy. ( Bermejo, F; de la Poza, G; Gisbert, JP; López-Sanroman, A; Marín-Jimenez, I; Muriel, A; Opio, V; Taxonera, C, 2012) |
"Appropriate treatment of perianal fistulas in Crohn's disease (CD) involves accurate anatomic evaluation." | 1.38 | Endoscopic ultrasound for perianal Crohn's disease: disease and fistula characteristics, and impact on therapy. ( Assulin, Y; Beer-Gabel, M; Chowers, Y; Lahat, A, 2012) |
"Presence/absence of history of perianal fistula was recorded." | 1.37 | CARD15 mutations and perianal fistulating Crohn's disease: correlation and predictive value of antibiotic response. ( Andrade, P; Donato, MM; Ferreira, M; Freire, P; Portela, F; Sofia, C, 2011) |
"Recto-urethral fistulas due to Crohn's disease are very uncommon." | 1.35 | [Urethral fistula due to Crohn's disease: case report of successful conservative management]. ( Borovicka, J; Engeler, DS; Hetzer, FH; Meyer, D; Schmid, HP; Schwab, C, 2008) |
"Biopsy examination showed malakoplakia with characteristic Michaelis-Gutmann bodies." | 1.33 | Rectal malakoplakia presenting as a mass and fistulous tract in a renal transplant patient. ( Abbas, Z; Mubarak, M; Yousif, M, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (58.82) | 29.6817 |
2010's | 6 (35.29) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
Authors | Studies |
---|---|
Breton, J | 1 |
Tanes, C | 1 |
Tu, V | 1 |
Albenberg, L | 1 |
Rowley, S | 1 |
Devas, N | 1 |
Hwang, R | 1 |
Kachelries, K | 1 |
Wu, GD | 1 |
Baldassano, RN | 1 |
Bittinger, K | 1 |
Mattei, P | 1 |
Ghahramani, L | 1 |
Minaie, MR | 1 |
Arasteh, P | 1 |
Hosseini, SV | 1 |
Izadpanah, A | 1 |
Bananzadeh, AM | 1 |
Ahmadbeigi, M | 1 |
Hooshanginejad, Z | 1 |
Dewint, P | 1 |
Hansen, BE | 3 |
Verhey, E | 1 |
Oldenburg, B | 1 |
Hommes, DW | 1 |
Pierik, M | 1 |
Ponsioen, CI | 1 |
van Dullemen, HM | 1 |
Russel, M | 1 |
van Bodegraven, AA | 1 |
van der Woude, CJ | 3 |
Elnaim, AK | 1 |
Mohamed, MM | 1 |
Thia, KT | 1 |
Mahadevan, U | 1 |
Feagan, BG | 1 |
Wong, C | 1 |
Cockeram, A | 1 |
Bitton, A | 1 |
Bernstein, CN | 1 |
Sandborn, WJ | 1 |
Freire, P | 1 |
Portela, F | 1 |
Donato, MM | 1 |
Ferreira, M | 1 |
Andrade, P | 1 |
Sofia, C | 1 |
de la Poza, G | 1 |
López-Sanroman, A | 1 |
Taxonera, C | 1 |
Marín-Jimenez, I | 1 |
Gisbert, JP | 1 |
Bermejo, F | 1 |
Opio, V | 1 |
Muriel, A | 1 |
Lahat, A | 1 |
Assulin, Y | 1 |
Beer-Gabel, M | 1 |
Chowers, Y | 1 |
Dejaco, C | 2 |
Harrer, M | 1 |
Waldhoer, T | 2 |
Miehsler, W | 2 |
Vogelsang, H | 2 |
Reinisch, W | 2 |
Rutgeerts, PJ | 1 |
West, RL | 2 |
Felt-Bersma, RJ | 1 |
van Tilburg, AJ | 1 |
Drapers, JA | 1 |
Kuipers, EJ | 2 |
Endtz, HP | 1 |
Ouwedijk, M | 1 |
Boelens, HA | 1 |
Kusters, JG | 1 |
Dignass, AU | 1 |
Yousif, M | 1 |
Abbas, Z | 1 |
Mubarak, M | 1 |
Atienza, P | 1 |
Angelberger, S | 1 |
Wehkamp, J | 1 |
Lichtenberger, C | 1 |
Schaeffeler, E | 1 |
Schwab, M | 1 |
Teml, A | 1 |
Schwab, C | 1 |
Meyer, D | 1 |
Hetzer, FH | 1 |
Borovicka, J | 1 |
Schmid, HP | 1 |
Engeler, DS | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Adalimumab for the Treatment of Perianal Fistulas in Crohn's Disease More Effective Alone or Combined to Ciprofloxacin[NCT00736983] | Phase 3 | 76 participants (Actual) | Interventional | 2008-09-30 | Completed | ||
A Prospective Longitudinal Study on the Effect of Tight Control Management on Perianal Crohn's Disease[NCT03861689] | 40 participants (Anticipated) | Interventional | 2019-07-01 | Enrolling by invitation | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for ciprofloxacin and Anal Fistula
Article | Year |
---|---|
An historical overview of the treatment of Crohn's disease: why do we need biological therapies?
Topics: Anti-Infective Agents; Biological Therapy; Ciprofloxacin; Crohn Disease; Glucocorticoids; Humans; Im | 2004 |
[Refractory perineal fistulas in Crohn's disease].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Ciprofloxacin; Crohn Diseas | 2007 |
6 trials available for ciprofloxacin and Anal Fistula
Article | Year |
---|---|
Antibiotic therapy for prevention of fistula in-ano after incision and drainage of simple perianal abscess: A randomized single blind clinical trial.
Topics: Abscess; Anti-Bacterial Agents; Antibiotic Prophylaxis; Anus Diseases; Ciprofloxacin; Drainage; Huma | 2017 |
Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI).
Topics: Adalimumab; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Mo | 2014 |
Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Crohn Disease; Double-Blind Method; Female; Humans; Mal | 2009 |
Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anus Diseases; Azathioprine; | 2003 |
Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study.
Topics: Adolescent; Adult; Anti-Infective Agents; Antibodies, Monoclonal; Ciprofloxacin; Crohn Disease; Doub | 2004 |
Perianal fistulas in Crohn's disease are predominantly colonized by skin flora: implications for antibiotic treatment?
Topics: Adult; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Corynebacterium Infections; Crohn | 2005 |
9 other studies available for ciprofloxacin and Anal Fistula
Article | Year |
---|---|
A Microbial Signature for Paediatric Perianal Crohn's Disease.
Topics: Ciprofloxacin; Crohn Disease; Ecosystem; Humans; Rectal Fistula; Treatment Outcome | 2022 |
Is vesicolithotomy with bladder wash the answer for rectovesical fistula secondary to neglected vesical stone? Complicated presentation but simple management.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Humans; Male; Rectal Fistula; Recurrence; Urinary Bladd | 2014 |
CARD15 mutations and perianal fistulating Crohn's disease: correlation and predictive value of antibiotic response.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Crohn Disease; Drug Therapy, Combination; Female; Genet | 2011 |
Genital fistulas in female Crohn's disease patients.: clinical characteristics and response to therapy.
Topics: Adalimumab; Adolescent; Adult; Age Factors; Anti-Infective Agents; Anti-Inflammatory Agents; Antibod | 2012 |
Endoscopic ultrasound for perianal Crohn's disease: disease and fistula characteristics, and impact on therapy.
Topics: Abscess; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Infective Agents; Anti-Inflammatory | 2012 |
[Management of perianal fistulizing Crohn's disease: a conservative approach].
Topics: Anti-Infective Agents; Ciprofloxacin; Combined Modality Therapy; Crohn Disease; Fecal Incontinence; | 2005 |
Rectal malakoplakia presenting as a mass and fistulous tract in a renal transplant patient.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Fissure in Ano; Fistula; Humans; Kidney Transplantation | 2006 |
NOD2/CARD15 gene variants are linked to failure of antibiotic treatment in perianal fistulating Crohn's disease.
Topics: Adult; Alleles; Anti-Infective Agents; beta-Defensins; Ciprofloxacin; Crohn Disease; Female; Genetic | 2008 |
[Urethral fistula due to Crohn's disease: case report of successful conservative management].
Topics: Azathioprine; Ciprofloxacin; Crohn Disease; Cystoscopy; Cystostomy; Diagnosis, Differential; Drug Th | 2008 |